RUS
- Main
- News centre
- Funds
- Management companies
- Deals
- Portfolio companies
- Consultants
- IPO/SPO
- Projects
- Comments
- Preqveca monthly
- IPO monthly
- Preqveca polls
- PREQVECA Awards
- Macro indicators
- Knowledge bank
- Newsletters
- About us
- Subscription
Details
| Name | Selecta Biosciences |
| Placement specification | common stock |
| Placement type | IPO |
| Subscription type | Public offering |
| Start of placement | 27.06.2016 |
| Status | Completed |
| End of placement | 27.06.2016 |
| Placement amount | 5 290 000 |
| Placement volume, mln. USD | 65 |
| Upper bound, USD | 14.00 |
| Lower bound, USD | 14.00 |
| Offering price, â USD | 14.00 |
| Trading floor | NASDAQ |
| Investment banks | Stifel Bank & Trust, UBS Investment Bank |
| Capitalisation at the moment of placement, mln. USD | 217 |
| Country of operation | Russia, USA |
| Industry | Biotechnologies and life sciences, Pharmaceutical industry |
This issuer is a portfolio company at the PE&VC funds
I2BF Venture Capital Fund II [Exited]